about
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and i...
Read More
39.85
0.33
(0.84%)
4.8M
XNYS Volume
XNYS 26 Sep, 2025 5:30 PM (EDT)
Low Financial Strength
Mid Valuation
Technically Neutral
Await Turnaround
These stocks are of poor quality, but mid-range financials and valuations. Their performance may improve based on financials, however our advise would be to be careful before buying these stocks.
View Similar
Embed DVM
GSK Plc ADR Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..